Detalhe da pesquisa
1.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Proc Natl Acad Sci U S A
; 118(15)2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876771
2.
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
Proc Natl Acad Sci U S A
; 116(2): 619-624, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30584090
3.
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Proc Natl Acad Sci U S A
; 116(45): 22730-22736, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624127
4.
A snapshot of COVID-19 infection in patients with solid tumors.
Int J Cancer
; 148(10): 2389-2397, 2021 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270902
5.
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
Gynecol Oncol
; 163(2): 334-341, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452746
6.
Light signals counteract alterations caused by simulated microgravity in proliferating plant cells.
Am J Bot
; 108(9): 1775-1792, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524692
7.
Inflammatory myofibroblastic tumour of an unusual presentation in the uterine cervix: a case report.
World J Surg Oncol
; 19(1): 331, 2021 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801049
8.
From Spaceflight to Mars g-Levels: Adaptive Response of A. Thaliana Seedlings in a Reduced Gravity Environment Is Enhanced by Red-Light Photostimulation.
Int J Mol Sci
; 22(2)2021 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33477454
9.
In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
Gynecol Oncol
; 156(2): 430-438, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839338
10.
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.
Oncologist
; 24(5): 680-687, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126859
11.
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
Gynecol Oncol
; 155(1): 144-150, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434613
12.
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
Gynecol Oncol
; 153(1): 158-164, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630630
13.
Trabectedin for reversing platinum resistance and resensitization to platinum in patients with recurrent ovarian cancer.
Future Oncol
; 15(3): 271-280, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465613
14.
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
Int J Gynecol Cancer
; 29(6): 1050-1056, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263024
15.
The combined effects of real or simulated microgravity and red-light photoactivation on plant root meristematic cells.
Planta
; 248(3): 691-704, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948124
16.
Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
Curr Oncol Rep
; 20(5): 40, 2018 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611060
17.
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia.
Br J Cancer
; 114(11): 1191-8, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27187687
18.
Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib.
Anticancer Drugs
; 26(1): 112-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25075797
19.
Oxylipin biosynthesis genes positively regulate programmed cell death during compatible infections with the synergistic pair potato virus X-potato virus Y and Tomato spotted wilt virus.
J Virol
; 87(10): 5769-83, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23487466
20.
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).
Clin Cancer Res
; 30(1): 176-186, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527007